SLC29A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.401200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.524800E-01
Normal-vs-Stage2
8.573600E-01
Normal-vs-Stage3
3.572400E-01
Normal-vs-Stage4
3.351200E-01
Stage1-vs-Stage2
7.306200E-01
Stage1-vs-Stage3
2.207400E-01
Stage1-vs-Stage4
1.448570E-01
Stage2-vs-Stage3
1.776390E-01
Stage2-vs-Stage4
6.360100E-02
Stage3-vs-Stage4
1.126220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.372800E-01
Normal-vs-AfricanAmerican
7.288600E-01
Normal-vs-Asian
7.689600E-01
Caucasian-vs-AfricanAmerican
7.098200E-01
Caucasian-vs-Asian
3.139600E-01
AfricanAmerican-vs-Asian
3.772400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.922400E-01
Normal-vs-Female
9.102800E-01
Male-vs-Female
4.870400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.508400E-01
Normal-vs-Age(41-60Yrs)
6.067000E-01
Normal-vs-Age(61-80Yrs)
9.966800E-01
Normal-vs-Age(81-100Yrs)
8.193200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.535800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.175000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.366000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.826100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.083800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.227600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.205200E-01
Normal-vs-Daily Drinker
5.715200E-01
Normal-vs-Weekly Drinker
8.032800E-01
Normal-vs-Occasional Drinker
5.278000E-01
Normal-vs-Social Drinker
8.010800E-01
Non Drinker-vs-Daily Drinker
3.046800E-01
Non Drinker-vs-Weekly Drinker
7.386400E-01
Non Drinker-vs-Occasional Drinker
1.118830E-01
Non Drinker-vs-Social Drinker
4.459800E-01
Daily Drinker-vs-Weekly Drinker
6.015800E-01
Daily Drinker-vs-Occasional Drinker
3.021600E-02
Daily Drinker-vs-Social Drinker
1.360590E-01
Weekly Drinker-vs-Occasional Drinker
1.131800E-01
Weekly Drinker-vs-Social Drinker
3.860600E-01
Occasional Drinker-vs-Social Drinker
4.129200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.888960E-01
Normal-vs-Grade 2
7.202500E-02
Normal-vs-Grade 3
1.046600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.606200E-01
Grade 1-vs-Grade 3
2.520400E-01
Grade 1-vs-Grade 4
1.888960E-01
Grade 2-vs-Grade 3
7.490600E-01
Grade 2-vs-Grade 4
7.202500E-02
Grade 3-vs-Grade 4
1.046600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.054400E-01
Normal-vs-NonDiabetic
8.915200E-01
Diabetic-vs-NonDiabetic
9.787600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.959800E-01
Normal-vs-NoPancreatitis
9.219600E-01
Pancreatitis-vs-NoPancreatitis
8.583600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.396600E-01
Normal-vs-N1
8.498000E-01
N0-vs-N1
6.888200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.620800E-01
Normal-vs-TP53-NonMutant
8.150800E-01
TP53-Mutant-vs-TP53-NonMutant
7.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
